Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AtriCure (ATRC) EPS (Weighted Average and Diluted) (2019 - 2026)

AtriCure (ATRC) reported EPS (Weighted Average and Diluted) of $0.0 for Q1 2026, up 101.57% year-over-year from $0.0 in Q1 2025, and down 94.49% on a QoQ basis from $0.04 in Q4 2025.

AtriCure (ATRC) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.0 in Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 101.57% year-over-year to $0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.1 (up 87.65% YoY) and the FY2025 annual result came in at -$0.24, up 74.74% from the prior year.
  • EPS (Weighted Average and Diluted) eased to $0.0 in Q1 2026 per ATRC's latest filing, from $0.04 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.04 in Q4 2025 and bottomed at -$0.33 in Q1 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.17 (2024), against an average of -$0.17.
  • The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) sank 133.33%; it then soared 112.12% in 2025.
  • Tracing ATRC's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.09 in 2022, then slumped by 133.33% to -$0.21 in 2023, then tumbled by 57.14% to -$0.33 in 2024, then surged by 112.12% to $0.04 in 2025, then plunged by 94.49% to $0.0 in 2026.
  • Per Business Quant, the three latest ATRC EPS (Weighted Average and Diluted) figures stand at $0.0 (Q1 2026), $0.04 (Q4 2025), and -$0.01 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.28
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -1.11
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 2.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.92
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.07
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.66
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.57
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -0.03
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.12
10 AtriCure 1.39 Bn 1.25 Bn 109.31 Mn 0.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.04
Sep 30, 2025 -0.01
Jun 30, 2025 -0.13
Mar 31, 2025 -0.14
Dec 31, 2024 -0.33
Sep 30, 2024 -0.17
Jun 30, 2024 -0.17
Mar 31, 2024 -0.28
Dec 31, 2023 -0.21
Sep 30, 2023 -0.20
Jun 30, 2023 -0.11
Mar 31, 2023 -0.14
Dec 31, 2022 -0.09
Sep 30, 2022 -0.27
Jun 30, 2022 -0.32
Mar 31, 2022 -0.33
Dec 31, 2021 -0.30
Sep 30, 2021 2.11
Jun 30, 2021 -0.36
Mar 31, 2021 -0.38
Dec 31, 2020 -0.43
Sep 30, 2020 -0.11
Dec 31, 2019 -0.43